Treatment of life-threatening post-haemorrhagic anaemia with cell-free haemoglobin solution in an adolescent Jehovah's Witness.
Severe blood loss carries an increased risk of a fatal outcome in patients who do not consent to the use of blood products. For patients who base this decision on a religious belief system, such as the Jehovah's Witnesses, important distinctions may exist between the appropriateness of various blood products. We describe the first successful use of purified human cell-free haemoglobin solution in a paediatric patient, in this case in the management of life-threatening anaemia in a 14-year-old female Jehovah's Witness with immune thrombocytopenia.
Anton
Natalie
N
Department of Critical Care Medicine, The Hospital for Sick Children, and the Interdepartmental Division of Critical Care Medicine, University of Toronto, Ontario, Canada.
Hitzler
Johann K
JK
Kavanagh
Brian P
BP
D000293:Adolescent; D000740:Anemia / Q000523:psychology / Q000628:therapy*; D002474:Cell-Free System; D003422:Critical Care; D005260:Female; D006454:Hemoglobins / Q000627:therapeutic use*; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D033221:Jehovah's Witnesses; D008595:Menorrhagia / Q000628:therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000628:therapy*
D006454:Hemoglobins